Evidence map›Paper›PMID 42714641›Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Exercise and pathologic complete response to cancer treatment: a systematic review and meta-analysis.

Nuno Dias Rato, Catarina Garcia, Diogo Pinto, Helena Guedes, Ana Joaquim, Sofia Viamonte, Luisa Helguero, João Viana, Alberto Alves

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nuno Dias RatoResearch Center in Sports Sciences, Health Sciences, and Human Development, University of Maia, Av. Carlos de Oliveira Campos, 4475-690, Maia, Portugal. nunodiasrato@umaia.pt.ORCID http://orcid.org/0000-0002-6077-2809
Catarina GarciaResearch Center in Sports Sciences, Health Sciences, and Human Development, University of Maia, Av. Carlos de Oliveira Campos, 4475-690, Maia, Portugal.ORCID http://orcid.org/0000-0003-1918-6231
Diogo PintoResearch Center in Sports Sciences, Health Sciences, and Human Development, University of Maia, Av. Carlos de Oliveira Campos, 4475-690, Maia, Portugal.ORCID http://orcid.org/0000-0002-4918-7190
Helena GuedesONCOMOVE© - Associação de Investigação de Cuidados de Suporte Em Oncologia, Avenida João Paulo II, nº 911, Loja 9, 4410-406, Arcozelo, Vila Nova de Gaia, Portugal.ORCID http://orcid.org/0000-0002-8346-8180
Ana JoaquimONCOMOVE© - Associação de Investigação de Cuidados de Suporte Em Oncologia, Avenida João Paulo II, nº 911, Loja 9, 4410-406, Arcozelo, Vila Nova de Gaia, Portugal.ORCID http://orcid.org/0000-0001-7064-9639
Sofia ViamonteONCOMOVE© - Associação de Investigação de Cuidados de Suporte Em Oncologia, Avenida João Paulo II, nº 911, Loja 9, 4410-406, Arcozelo, Vila Nova de Gaia, Portugal.ORCID http://orcid.org/0000-0003-2224-9256
Luisa HelgueroInstitute of Biomedicine, School of Health Sciences, University of Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal.ORCID http://orcid.org/0000-0001-8237-2390
João VianaResearch Center in Sports Sciences, Health Sciences, and Human Development, University of Maia, Av. Carlos de Oliveira Campos, 4475-690, Maia, Portugal.ORCID http://orcid.org/0000-0002-9147-7781
Alberto AlvesResearch Center in Sports Sciences, Health Sciences, and Human Development, University of Maia, Av. Carlos de Oliveira Campos, 4475-690, Maia, Portugal.ORCID http://orcid.org/0000-0001-9484-7349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNeoadjuvant chemotherapy (NACT) is a commonly recommended approach for treating several cancers, and improving patients' outcomes to this therapy is important. This systematic review and meta-analysis assessed the impact of exercise on pathologic complete response (pCR), a key short-term marker of treatment efficacy, in patients with solid tumors receiving NACT.

methodsFour electronic databases were searched for randomized controlled trials with physical exercise during NACT as an intervention published until May 2025. Risk of bias was assessed using Cochrane RoB 2.0 and the TESTEX scale. A random-effect meta-analysis using the inverse variance method synthesized the results. Heterogeneity was assessed using I

resultsEight studies involving 504 patients with breast, esophageal, gastric, or rectal cancer were included in the final analysis. Exercise interventions consisted of aerobic and resistance exercise. Overall, there were no significant differences between exercise and control groups in the rate of pCR to NACT (pooled risk ratio: 1.08 (95% CI: 0.82 to 1.43) Z = 0.56, p = 0.58). However, meta-regression data from breast cancer (BC) studies (4 studies, 367 participants) suggest exercise may be associated with enhanced tumor response to NACT in HR + /HER2- subtypes (regression coefficient: 0.83 (95% CI: -0.00 to 1.67), p = 0.05).

conclusionExercise during NACT did not improve pCR across cancer types. Exploratory meta-regression findings suggest a possible benefit of exercise in BC patients with the HR + /HER2- subtype. These results should be interpreted with caution due to the small number of studies and low certainty of the evidence.

Indexed as

ExerciseExercise TherapyNeoadjuvant TherapyNeoplasmsBreast NeoplasmsFemaleHumansPathologic Complete ResponseRandomized Controlled Trials as TopicExercise oncologyMeta-analysisNeoadjuvant chemotherapyPathologic responsePhysical exerciseRandomized controlled trials

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.